As of June 17, 2025, Innovation Pharmaceuticals Inc (IPIX) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Innovation Pharmaceuticals Inc's Forward P/E to Peers
To better understand Innovation Pharmaceuticals Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Innovation Pharmaceuticals Inc (IPIX) | - |
| Ocuphire Pharma Inc (OCUP) | 9.27 |
| Sunshine Biopharma Inc (SBFM) | 2.11 |
| Aptorum Group Ltd (APM) | 0.02 |
Compared to its competitors, Innovation Pharmaceuticals Inc's Forward P/E is difficult to compare due to insufficient data.